Purpose of the Procedure
- Determine patient eligibility for immunotherapy.
- Predict tumor response to checkpoint inhibitors.
- Provide precise data for personalized treatment plans.
Book TMB Assessment in Saudi Arabia | Lahalak Medical Platform
An advanced biomarker assessment that quantifies genetic mutations within tumor cells. This critical test helps oncologists predict your response to immunotherapy, enabling a personalized and highly effective treatment strategy for cancer.
Scientific name: Tumor Mutational Burden (TMB) Assessment
This genetic test quantifies the number of mutations within tumor DNA. It serves as a vital biomarker to identify patients likely to benefit from immune checkpoint inhibitors, optimizing oncology treatment precision.
Service type
Advanced Genetic Test
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Sample collection or biopsy processing
- DNA sequencing analysis
- Detailed medical report
Medical Service Information
Target Groups
- Patients with advanced solid tumors.
- Patients with non-small cell lung cancer (NSCLC).
- Patients with advanced melanoma.
Frequently Asked Questions
- Does the test require fasting? No, fasting is not required.
- When will results be ready? Typically within 10 to 14 business days.
Conditions & Notices
- Requires a previous tissue biopsy or fresh blood sample
- Previous oncology medical reports must be provided
Medical services you might also like
